Association of Selenium and Thyroid Cancer
A Comprehensive Systematic Review
Keywords:
selenium, selenium binding protein (SBP), thyroid carcinoma, thyroid cancerAbstract
Introduction: Selenium's historical journey from discovery to its role in human health underscores its complex relationship with disease, particularly thyroid cancer. While research suggests a potential link between low selenium levels and thyroid cancer risk, conflicting findings challenge our understanding of selenium's impact, warranting further investigation. This systematic review aims to unravel selenium's intricate interplay with thyroid cancer, navigating through its historical significance, physiological role, and recent epidemiological studies to offer insights into this complex relationship. Method: The researchers in this study followed the 2020 Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) guidelines to ensure that their work met the required standards. This was done to ensure the precision and reliability of the conclusions derived from the research. Result: Our search produced 18 results. After looking at the titles and summaries, we found 7 papers that fit our criteria. At first, we excluded several articles because they were written in review style, pilot study, and case reports. But after reading the full papers carefully, we included five papers in our final analysis. These papers included experimental study, cross-sectional study, prospective cohort, and case control. Conclusion: This systematic review explores the relationship between selenium and thyroid cancer, highlighting SBP1 as a potential therapeutic target based on experimental evidence. Clinical studies suggest lower serum selenium levels in females with papillary thyroid cancer, indicating a potential protective effect with higher selenium levels. While the development of a tumor-targeted drug delivery system shows promise for thyroid cancer treatment, a large prospective cohort study found no association between selenium intake and thyroid cancer risk, emphasizing the need for further research, particularly biomarker-based studies.
References
Hao, R. et al. (2023) ‘Relationship between Serum Levels of Selenium and Thyroid Cancer: A Systematic Review and Meta-Analysis’, Nutrition and Cancer, 75(1), pp. 14–23. doi: 10.1080/01635581.2022.2115082.
Baltaci AK, Dundar TK, Aksoy F, Mogulkoc R. Changes in the serum levels of trace elements before and after the operation in thyroid cancer patients. Biol Trace Elem Res. 2017;175(1):57–64. doi:10.1007/s12011-016-0768-2
Duntas LH, Benvenga S. Selenium: an element for life. Endocrine. 2015;48(3):756–75. doi:10.1007/s12020-014-0477-6
Kucharzewski M, Braziewicz J, Majewska U, Góźdź S. Concentration of selenium in the whole blood and the thyroid tissue of patients with various thyroid diseases. Biol Trace Elem Res. 2002;88(1):25–30. doi:10.1385/BTER:88:1:25
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71(3):209–49. doi:10.3322/caac.21660
Jonklaas J, Danielsen M, Wang H. A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid. 2013;23(9):1079-1086. doi:10.1089/thy.2012.0548
Miranda-Filho A, Lortet-Tieulent J, Bray F, et al. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225-234. doi:10.1016/S2213-8587(21)00027-9
Chiu-Ugalde J, Wirth EK, Klein MO, et al. Thyroid function is maintained despite increased oxidative stress in mice lacking selenoprotein biosynthesis in thyroid epithelial cells. Antioxid Redox Signal. 2012;17(6):902-913. doi:10.1089/ars.2011.4055
Ma, J., Huang, X., Xu, J. et al. SBP1 promotes tumorigenesis of thyroid cancer through TXN/NIS pathway. Mol Med 29, 121 (2023). https://doi.org/10.1186/s10020-023-00700-y
Ge S, Zhao J, Yao J, Fu H, Tian Y, Shan Y, Sun M, Feng J, Dong J and Liao L (2023) The association between serum selenium levels and pathological features of papillary thyroid cancer in 284 patients. Front. Endocrinol. 14:1242250. Doi: 10.3389/fendo.2023.1242250
Xiangcai Zou, Zhipeng Jiang, Liang Li & Zonghai Huang (2021) Selenium nanoparticles coated with pH responsive silk fibroin complex for fingolimod release and enhanced targeting in thyroid cancer, Artificial Cells, Nanomedicine, and Biotechnology, 49:1, 83-95, DOI: 10.1080/21691401.2021.1871620
O’Grady TJ, Kitahara CM, DiRienzo AG, Gates MA (2014) The Association between Selenium and Other Micronutrients and Thyroid Cancer Incidence in the NIH-AARP Diet and Health Study. PLoS ONE 9(10): e110886. doi:10.1371/journal.pone.0110886
Ren Y, Kitahara CM, Berrington de Gonzalez A, et al. Lack of association between fingernail selenium and thyroid cancer risk: a case-control study in French Polynesia. Asian Pac J Cancer Prev. 2014;15(13):5187-5194. doi:10.7314/apjcp.2014.15.13.5187
Hung J, Lu Y, Wang Y, et al. FTY720 induces apoptosis in hepatocellular carcinoma cells through activation of protein kinase C delta signaling. Cancer Res. 2008;68(4): 1204–1212. [46]
Kalhori V, Magnusson M, Asghar M, et al. FTY720 (Fingolimod) attenuates basal and sphingosine-1-phosphateevoked thyroid cancer cell invasion. Endocr Relat Cancer. 2016; 23(5):457–468.
Ibrahimpasic T, Ghossein R, Shah JP, Ganly I. Poorly differentiated carcinoma of the thyroid gland: current status and future prospects. Thyroid: official journal of the American Thyroid Association. 2019;29(3):311–21.
Elhodaky M, Diamond AM. Selenium-binding protein 1 in human Health and Disease International journal of molecular sciences. 2018;19(11).
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Daniel Setiawan Nathan, Hoo Yumilia (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors publishing here keep copyright but grant the journal first publication rights, under a Creative Commons Attribution-NonCommercial 4.0 License. They can distribute their work non-exclusively elsewhere with an acknowledgment of its first publication in this journal. Posting the work online before and during submission for earlier and greater citation is encouraged, reflecting Open Access benefits.
